Comparison of Serum Procalcitonin Levels in Patients with Gram-Negative and Gram-Positive Sepsis
DOI:
https://doi.org/10.51253/pafmj.v74iSUPPL-2.12190Keywords:
Antimicrobial Resistance, Blood Culture, Procalcitonin, SepsisAbstract
Objective: To compare rise of serum Procalcitonin levels in patients with culture-proven Gram-negative and Gram-positive sepsis.
Study Design: Cross-sectional study
Place and Duration of Study: Department of Chemical Pathology in collaboration with the Department of Microbiology, Army Medical College at Pak Emirates Military Hospital, Rawalpindi, Pakistan, from Nov 2022 to Nov 2023.
Methodology: Five hundred and twenty-four blood samples were analyzed. Blood culture samples were analyzed on the fully automated Biomerieux Bact /Alert 3D system. Bacterial growth was confirmed after incubation at 35°C±2°C ambient air as per Clinical Laboratory Standards Institute guidelines. All samples which showed no growth were discarded after five days.
For Procalcitonin analysis, 3ml of peripheral venous blood was collected in a serum plain tube. The serum was separated within 1 hour after collection by centrifugation at 4000rpm. Procalcitonin levels were then measured by Electro-Chemiluminescence immunoassay on the Roche COBAS 6000 chemistry analyzer as per reagent kit literature.
Three hundred and seventy-two samples showed growth on blood culture and were included.
Results: Out of 372 blood cultures, 195(52.4%) were positive for Gram-negative and 177(47.6%) for Gram-positive isolates. The median serum Procalcitonin levels in Gram-negative group were significantly higher than Gram-positive group (p-value<0.001). ROC curve analysis revealed PCT has a sensitivity of 65.6% and specificity of 78% at a cut-off of 3ng/mL for distinguishing Gram-negative from Gram-positive sepsis.
Conclusion: Serum PCT levels were significantly elevated in Gram-negative compared to Gram-positive septicemia.
Downloads
References
Kim HI, Park S. Sepsis: Early Recognition and Optimized Treatment. Tuberculosis and respiratory diseases. 2019; 82(1): 6-14.
https://doi.org/10.4046/trd.2018.0041
Strich JR, Heil EL, Masur H. Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial Resistance. The Journal of infectious diseases. 2020; 222(Suppl 2): S119-s31. https://doi.org/10.1093/infdis/jiaa221
CECCONI, M., EVANS, L., LEVY, M. & RHODES, A. 2018. Sepsis and septic shock. Lancet, 392, 75-87.
https://doi.org/10.1016/S0140-6736(18)30696-2
ANGGRAINI, D., HASNI, D. & AMELIA, R. J. S. J. 2022. Pathogenesis of Sepsis. 1, 332-339.
https://doi.org/10.1146/annurev-pathol-011110-130327
OPAL, S. M. & COHEN, J. J. C. C. M. 1999. Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? 27, 1608-1616.
https://doi.org/10.4161/viru.27024
CABRAL, L., AFREIXO, V., MEIRELES, R., VAZ, M., FRADE, J.-G., CHAVES, C., CAETANO, M., ALMEIDA, L., PAIVA, J.-A. J. J. O. B. C. & RESEARCH 2019. Evaluation of procalcitonin accuracy for the distinction between Gram-negative and Gram-positive bacterial sepsis in burn patients. 40, 112-119.
https://doi.org/10.1093/jbcr/iry058
Lee H. Procalcitonin as a biomarker of infectious diseases. The Korean journal of internal medicine. 2013; 28(3): 285-91.
https://doi.org/10.3904/kjim.2013.28.3.285
Covington EW, Roberts MZ, Dong J. Procalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current Literature. Pharmacotherapy. 2018; 38(5): 569-81
https://doi.org/10.1002/phar.2112
Li S, Rong H, Guo Q, Chen Y, Zhang G, Yang J. Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences. 2016; 21: 39https://doi.org/10.4103/1735-1995.183996
Bibi A, Basharat N, Aamir M, Haroon ZH. Procalcitonin as a biomarker of bacterial infection in critically ill patients admitted with suspected Sepsis in Intensive Care Unit of a tertiary care hospital. Pakistan journal of medical sciences. 2021; 37(7): 1999-2003.
https://doi.org/10.12669/pjms.37.7.4183
Jensch, a., mahla, e., toller, w., herrmann, m. & mangge, h. 2021a. Procalcitonin measurement by Diazyme™ immunturbidimetric and Elecsys BRAHMS™ PCT assay on a Roche COBAS modular analyzer. Clin Chem Lab Med, 59, e362-e366.
https://doi.org/10.1515/cclm-2020-1541
Jensch, a., mahla, e., toller, w., herrmann, m., mangge, h. J. C. C. & medicine, l. 2021b. Procalcitonin measurement by Diazyme™ immunturbidimetric and Elecsys BRAHMS™ PCT assay on a Roche COBAS modular analyzer. 59, e362-e366
https://doi.org/10.1515/cclm-2020-1541
He X, Chen L, Chen H, Feng Y, Zhu B, Yang Cjbc, et al. Diagnostic accuracy of procalcitonin for bacterial infection in liver failure: a meta-analysis. 2021;2021.
https://doi.org/10.1155/2021/5801139
Cavaliere, f., biancofiore, g., bignami, e., derobertis, e., giannini, a., grasso, s. et al. 2019. Ayear in review in Minerva Anestesiologica 2018. Critical care. Experimental and clinical studies. 85, 95-105.
https://doi.org/10.2376/S0375-9393.21.16409
Kolonitsiou, f., papadimitriou-olivgeris, m., spiliopoulou, a., stamouli, v., papakostas, v., apostolopoulou, e et al. 2017. Trends of Bloodstream Infections in a University Greek Hospital during a Three-Year Period: Incidence of Multidrug-Resistant Bacteria and Seasonality in Gram-negative Predominance. Pol J Microbiol, 66, 171-180. https://doi.org/10.5604/01.3001.0010.7834
Holmes, c. L., anderson, m. T., mobley, h. L. T. & bachman, m. A. 2021. Pathogenesis of Gram-Negative Bacteremia. Clin Microbiol Rev, 34.
https://doi.org/10.1128/cmr.00234-20
Diekema, d. J., hsueh, p. R., mendes, r. E., pfaller, m. A., rolston, k. V., sader, h. S. & jones, r. N. 2019. The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother, 63. https://doi.org/10.1128/aac.00355-19
Guo, s. Y., zhou, y., hu, q. F., yao, j. & wang, h. 2015. Procalcitonin is a marker of gram-negative bacteremia in patients with sepsis. Am J Med Sci, 349, 499-504.
https://doi.org/10.1097/MAJ.0000000000000477
Wang, s., xie, z. & shen, z. 2019. Serum procalcitonin and C-reactive protein in the evaluation of bacterial infection in generalized pustular psoriasis. An Bras Dermatol, 94, 542-548.
https://doi.org/10.1016/j.abd.2019.09.022
Wang, s., xie, z. & shen, z. 2019. Serum procalcitonin and C-reactive protein in the evaluation of bacterial infection in generalized pustular psoriasis. An Bras Dermatol, 94, 542-548.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Basma Bukhari, Uzma Naeem, Afshan Bibi, Javaid Usman, Dr. Qurat ul ain Mustafa, Saima Bashir
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
